Summit Therapeutics (SMMT) Slip Before Earnings

Summit Therapeutics PLC (NASDAQ: SMMT) shares fell 3.1% to $8.98, as the company is projected to report its quarterly earnings at $3.01 per share on revenue of $8.03 million. Share volume was 22,000, compared to an all-day average of 156,000